𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab

✍ Scribed by A-L. Chew; A. Bennett; C.H. Smith; J. Barker; B. Kirkham

Book ID
108667675
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
156 KB
Volume
151
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Successful treatment of psoriatic onycho
Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab
✍ T. Bongartz; P. HΓ€rle; S. Friedrich; S. Karrer; T. Vogt; A. Seitz; U. MΓΌller-Lad πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Abstract Psoriatic onycho‐pachydermo periostitis (POPP) is recognized as a rare subset of psoriatic arthritis, characterized by psoriatic onychodystrophy, connective tissue thickening above the distal phalanx, and a periosteal reaction. Therapy for this rare disease is based on treatments used f

Treatment of psoriasis with adalimumab
Treatment of psoriasis with adalimumab
✍ G. Pitarch; J. L. Sanchez-Carazo; L. Mahiques; M. A. Perez-Ferriols; J. M. Forte πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 447 KB
Adalimumab for long-term treatment of ps
Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial
✍ Dafna D. Gladman; Philip J. Mease; Christopher T. Ritchlin; Ernest H. S. Choy; J πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of treatment with adalimumab, a fully human anti–tumor necrosis factor (anti‐TNF) monoclonal antibody, over 48 weeks in patients with moderate to severe psoriatic arthritis (PsA). ## Methods Patients who completed the Adalimumab Effect